Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Focal segmental glomerulosclerosis in children

E Ingulli1, A Tejani

  • 1University of Minnesota, Minneapolis, USA.

Current Opinion in Pediatrics
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benign prostatic hypertrophy: update on drug therapy.

Canadian family physician Medecin de famille canadien·2007
Same author

CD154+ graft antigen-specific CD4+ T cells are sufficient for chronic rejection of minor antigen incompatible heart grafts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.

Issues in emerging health technologies·2006
Same author

Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2002
Same author

The contribution of renal transplantation to final adult height: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Pediatric nephrology (Berlin, Germany)·2002
Same author

Acute and chronic rejection.

Seminars in nephrology·2001

Idiopathic focal segmental glomerulosclerosis (FSGS) in children often leads to kidney failure despite standard treatments. This review explores clinical features, outcomes, and emerging therapies for pediatric FSGS, offering new insights into its causes.

Area of Science:

  • Pediatric Nephrology
  • Glomerular Diseases
  • Renal Pathology

Background:

  • Idiopathic focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome in children.
  • Unlike minimal change disease, FSGS frequently progresses to end-stage renal disease (ESRD) in pediatric populations.
  • Standard proteinuria treatments are often ineffective, increasing complication risks and the likelihood of ESRD.

Purpose of the Study:

  • To review the clinical presentation and outcomes of pediatric idiopathic FSGS.
  • To evaluate the efficacy of novel therapeutic strategies for managing FSGS in children.
  • To explore potential causative factors and provide new insights into the pathogenesis of FSGS.

Main Methods:

  • Literature review of clinical studies on pediatric idiopathic FSGS.

Related Experiment Videos

  • Analysis of treatment responses to standard and emerging therapies.
  • Synthesis of current research on the underlying mechanisms of FSGS.
  • Main Results:

    • Pediatric FSGS presents with nephrotic syndrome but has a poorer prognosis than minimal change disease, often leading to renal failure.
    • Many patients do not respond adequately to conventional therapies, necessitating exploration of alternative treatments.
    • Recurrence of FSGS post-kidney transplantation remains a significant concern.

    Conclusions:

    • Idiopathic FSGS in children poses a substantial risk for progressive kidney disease and ESRD.
    • Newer treatment options show promise but require further investigation for optimal use in pediatric FSGS.
    • Understanding the factors contributing to FSGS development is crucial for improving patient outcomes and preventing recurrence.